Favipiravir: A new and emerging antiviral option in COVID-19
Favipiravir was quite safe with no demonstrable side effects. .out to a loading dose of 18 tablets on the first day and then 8 tablets a day for the Role in SARS-CoV-2 Clinical trials in COVID-19
Product details
Packaging Type | Bottles |
Strength | 400 mg |
Quantity Unit | Tablet |
Composition | Favipiravir |
Treatment | COVID-19-Antiviral |
Prescription/Non prescription | Prescription |
Packaging Size | 17 tablets |
Brand | Favitra |
Manufacturer | Intas Pharmaceuticals Ltd |
Form | Tablet |
![]() |
SUNESTA LIFE SCIENCES
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |